✦ LIBER ✦

Successful treatment with pulse cyclophosphamide of a steroid-refractory hepatitic variant of liver acute graft-vs.-host disease in a child

✍ Scribed by Yuta Kawahara; Akira Morimoto; Aki Masuzawa; Takae Ikeda; Tomomi Hayase; Yoshifumi Kashii; Yasuyuki Nozaki; Nobuyuki Kanai; Mariko Y. Momoi

Book ID: 115100109
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 252 KB
Volume: 16
Category: Article
ISSN: 1397-3142
DOI: 10.1111/j.1399-3046.2012.01664.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Successful treatment of steroid-refracto

Successful treatment of steroid-refractory hepatitic variant of liver graft-vs-host disease with pulse cyclophosphamide

✍ Jiri Mayer; Marta Krejci; Zdenek Pospisil; Michael Doubek; Andrea Janikova; Dani 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 193 KB

321: Successful therapy of steroid-refra

321: Successful therapy of steroid-refractory acute graft-versus host disease with sequential alemtuzumab

✍ R. Repp; A. Claviez; A. Schrauder; N. Schub; B. Gahn; M. Gramatzki 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 48 KB

Long-term follow-up of patients treated

Long-term follow-up of patients treated with daclizumab for steroid-refractory acute graft-vs-host disease

✍ Perales, M-A; Ishill, N; Lomazow, W A; Weinstock, D M; Papadopoulos, E B; Dastig 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 153 KB

Treatment of severe steroid refractory a

Treatment of severe steroid refractory acute graft-versus-host disease with infliximab, a chimeric human/mouse antiTNFα antibody

✍ Kobbe, G; Schneider, P; Rohr, U; Fenk, R; Neumann, F; Aivado, M; Dietze, L; Kron 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 66 KB

Long term outcome of patients with stero

Long term outcome of patients with steroid-refractory acute intestinal graft versus host disease after treatment with pentostatin

✍ Stefan A. Klein; Gesine Bug; Sabine Mousset; Wolf-Karsten Hofmann; Dieter Hoelze 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 194 KB

306: Successful phase II trial using mes

306: Successful phase II trial using mesenchymal stem cells (MSC) in combination with steroid therapy for the primary treatment of acute graft-vs-host disease (aGVHD)

✍ P. Kebriaei; L. Isola; E. Bahceci; H.K. Holland; S. Rowley; J. McGuirk; M. Devet 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 60 KB